Momenta Pharmaceuticals to Webcast at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

25th Annual Credit Suisse Healthcare ConferenceMonday, November 7, 2016 at 1:00 p.m. MST in Scottsdale, AZ

Stifel 2016 Healthcare ConferenceWednesday, November 16, 2016 at 11:45 a.m. EST in New York, NY

The audio webcast of each presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com.  A replay of each presentation will be posted on the Momenta website approximately one hour after the event.

About MomentaMomenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact:
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
[email protected]

Source: Momenta Pharmaceuticals, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Li Auto Inc. Investors to Inquire About Securities Class Action Investigation – LI
• High Income Securities Fund Announces Non-Transferable Rights Offering
• XTI Aerospace Files Form 10-K for Fiscal 2023 and Recaps Recent Developments